Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
BMJ Open|December 16, 2016
Should all anticoagulated patients with head injury receive a CT scan? Decision-analysis modelling of an observational cohortMaxine Kuczawski, Matt Stevenson, Steve Goodacre, et al.
Pharmacoeconomics|December 6, 2011
Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisalClaire McKenna, Emma Maund, Muhammad Sarowar, et al.
Health Technology Assessment (Winchester, England)|October 16, 2023
Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysisAndrew Metry, Abdullah Pandor, Shijie Ren, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Effectiveness of psychosocial interventions for adults with substance use disorder that have a co-occurring mental health disorder: an umbrella review and illustrative cost-effectiveness analysisEmma Simpson, Sunhong Kwon, Munira Essat, et al.
Pharmacoeconomics|April 9, 2015
Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatt Stevenson, Abdullah Pandor, John W Stevens, et al.
Pharmacoeconomics|October 23, 2016
Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBenjamin Kearns, Abdullah Pandor, Matt Stevenson, et al.
BMJ Open|January 15, 2017
AHEAD Study: an observational study of the management of anticoagulated patients who suffer head injurySuzanne Mason, Maxine Kuczawski, M Dawn Teare, et al.
Health Technology Assessment (Winchester, England)|March 22, 2014
Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysisMatt Stevenson, Tim Gomersall, Myfanwy Lloyd Jones, et al.
Pharmacoeconomics|May 28, 2017
Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology AppraisalIñigo Bermejo, Matt Stevenson, Rachel Archer, et al.
BMJ Open|June 19, 2017
How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysisKyla H Thomas, Deborah Caldwell, Michael N Dalili, et al.
Pageof 7